Nearly 600,000 U.S. Kids Had COVID Last Week

WEDNESDAY, January 12, 2022 — In a sign that the highly contagious variant of Omicron spares no-one, a new report shows that new COVID-19 cases among American children rose to more than 580,000 in the week ending January 1. 6, up 78% from the previous week. “With many children still not immunized – or too … Read more

Pfizer Says Omicron-Specific Vaccine Ready by March

Tuesday, January 11, 2022 – Pfizer Inc. said. On Tuesday, a COVID-19 vaccine that specifically targets the Omicron variant will be ready by March. Albert Burla, CEO of Pfizer, said the company has already started making the new version of the vaccine CNBCSquawk Box for “Squawk Box” CBS News mentioned. Omicron now accounts for more … Read more

Medicare Proposes to Only Cover Alzheimer’s Drug Aduhelm for Use in Clinical Trials

Written by Ernie Mondel and Dennis Thompson, HealthDay Reporters> TUESDAY, Jan 11, 2022 — It’s a move that could severely limit the number of people taking controversial new Alzheimer’s drug Aduhelm: Medicare proposed Tuesday to cover the cost of the expensive drug only for people enrolled in approved clinical trials. A final decision on coverage … Read more

Drug Combo Boosts Outcomes for Advanced Melanoma

Written by Amy Norton HealthDay Reporter > MONDAY, January 10, 2022 — For people diagnosed with advanced skin cancer, a combination of two immunotherapy drugs can double the time the cancer remains free of progression, according to a clinical trial. The treatment combines two drugs known as immune checkpoint inhibitors. One, called nivolumab (Opdivo), is … Read more

Scientists Work Out How Exercise Saves Your Brain

By Dennis Thompson, HealthDay reporter > Monday, January 10, 2022 — Exercise helps you stay fit and healthy, and researchers say it may also help you stave off dementia and Alzheimer’s disease. Now they have a better understanding of the hidden benefits that help the brain. A new study reports that older people who are … Read more

Medicare May Rethink Premium Hike for Pricey Alzheimer’s Drug

MONDAY, January 10, 2022 — Medicare has been asked to reassess a significant premium increase it had said stemmed in large part from the new, expensive Alzheimer’s drug, Aduhelm. US Health and Human Services Secretary Xavier Becerra’s directive, announced Monday, comes shortly after Aduhelm-based manufacturer Biogen slashed the drug’s price by nearly half, from $56,000 … Read more